Relmada Therapeutics, Inc. (RLMD)
3.58
+0.14
(+4.07%)
USD |
NASDAQ |
Oct 30, 16:00
3.595
+0.02
(+0.42%)
After-Hours: 20:00
Relmada Therapeutics Price to Book Value : 1.849 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.849 |
| October 29, 2026 | 1.776 |
| October 28, 2026 | 1.73 |
| October 27, 2026 | 1.658 |
| October 26, 2026 | 1.668 |
| October 23, 2026 | 1.689 |
| October 22, 2026 | 1.699 |
| October 21, 2026 | 1.658 |
| October 20, 2026 | 1.735 |
| October 19, 2026 | 1.632 |
| October 16, 2026 | 1.601 |
| October 15, 2026 | 1.652 |
| October 14, 2026 | 1.673 |
| October 13, 2026 | 1.735 |
| October 12, 2026 | 1.813 |
| October 09, 2026 | 1.751 |
| October 08, 2026 | 1.637 |
| October 07, 2026 | 1.678 |
| October 06, 2026 | 1.694 |
| October 05, 2026 | 1.797 |
| October 02, 2026 | 1.859 |
| October 01, 2026 | 1.890 |
| September 30, 2026 | 1.947 |
| September 29, 2026 | 1.926 |
| September 28, 2026 | 1.957 |
| Date | Value |
|---|---|
| September 25, 2026 | 1.978 |
| September 24, 2026 | 1.968 |
| September 23, 2026 | 1.952 |
| September 22, 2026 | 2.190 |
| September 21, 2026 | 2.148 |
| September 18, 2026 | 2.128 |
| September 17, 2026 | 2.169 |
| September 16, 2026 | 2.179 |
| September 15, 2026 | 2.293 |
| September 14, 2026 | 2.293 |
| September 11, 2026 | 2.334 |
| September 10, 2026 | 2.102 |
| September 09, 2026 | 2.112 |
| September 08, 2026 | 2.195 |
| September 04, 2026 | 2.288 |
| September 03, 2026 | 2.257 |
| September 02, 2026 | 2.344 |
| September 01, 2026 | 2.303 |
| August 31, 2026 | 2.252 |
| August 28, 2026 | 2.236 |
| August 27, 2026 | 2.334 |
| August 26, 2026 | 2.350 |
| August 25, 2026 | 2.370 |
| August 24, 2026 | 2.365 |
| August 21, 2026 | 2.391 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.770 |
| Corcept Therapeutics, Inc. | 12.40 |
| Veru, Inc. | 1.316 |
| Johnson & Johnson | 8.066 |
| Eli Lilly & Co. | 33.13 |
Price to Book Value Related Metrics
| Price | 3.58 |
| Earnings Yield | -25.98% |
| Market Cap | 381.88M |